Useful Information for Partner NGOs

Let’s treat of Hepatitis C


We are happy to present video blog of Anton Basenko, who had been waiting for Hepatitis C treatment for over 13 years and got a great chance to receive free therapy with innovative drugs within the Alliance treatment program.

Anton will share his fairs before starting the therapy, will tell about the choice of drugs, side effects and other interesting facts in 6 episodes. Please follow the links below to watch the videos. Please turn on the english subtitles in the bottom right corner of the video screen.
The program of Hepatitis C treatment with direct-acting antivirals implemented by Alliance since 2015 already allowed more than 1,200 people get access to free treatment. Among those, who have completed their therapy courses, treatment success rate is 93%. The efforts of Alliance allowed bringing the price for sofosbuvir down to USD 300 per vial; besides, sofosbuvir and other direct-acting antivirals were registered in Ukraine, included into the treatment protocol as well as into the list of drugs procured with state and local budget funds.
In 2017, Alliance for the first time in Ukraine will be using an interferon-free treatment regimen (sofosbuvir/ledipasvir) for patients with hepatitis C.
Follow Anton’s story on our  Facebook

Episode 1 – It happened!

Episode 2 – Expecting the miracle

Episode 3 – Shocking truth

Episode 4 – Side effects? No idea!


HIV self-testing with rapid tests

If you would like to do HIV self-testing with rapid tests, please carefully read the text below.

  • HIV infection is a chronic disease, which is treated with special medications (antiretroviral therapy) and allows the person to live a normal life.
  • HIV self-testing (HIVST) refers to a process in which a person collects his or her own blood specimen and then performs an HIV test and interprets the result, often in a private setting, either alone or with someone he or she trusts. As with all approaches to HIV testing, HIV self-testing should always be voluntary, not coercive or mandatory. 
  • reactive (positive) self-test result always requires further testing and confirmation from a trained medical professional in line with the national testing algorithm. It is important to understand that a positive self-test result does not provide a definitive HIV-positive diagnosis.
  • HIV self-testing with rapid tests is not recommended for people with a known HIV status who are taking ARV drugs as this may lead to a false non-reactive (negative) result.
  • Interpretation of a non-reactive (negative) self-test resultwill depend on the ongoing risk of HIV exposure. Individuals at high ongoing risk, or who test within six weeks of possible HIV exposure, should retest. 
  • A non-reactive self-test result does not always indicate an HIV-negative status. The accuracy of results can depend on the test used, possible errors in performing the self-test or interpreting the results, as well as the limitations of testing in the window period before an HIV infection is detectable (first weeks after being infected).
  • It is important to understand that HIV self-test results should not be used to justify in HIV risk behavior such as condomless sex following a negative self-test result. Since a negative self-test result does not always indicate that a person is HIV-negative, it is recommended to utilize the existing HIV prevention options, such as condoms.

If you have any questions about self-testing or its results or in case you would like to get more detailed information on HIV prevention, diagnostics and care, please call our doctors at +38 (050) 425 00 46 or +38 (050) 425 00 36.

Before self-testing, please carefully read the instruction for use of the rapid test to detect antibodies to HIV 1/2, watch the video  and read the leaflet .